Back to Search
Start Over
An appraisal of allergic disorders in India and an urgent call for action
- Source :
- World Allergy Organization Journal, Vol 13, Iss 7, Pp 100446-(2020), The World Allergy Organization Journal
- Publication Year :
- 2020
- Publisher :
- Elsevier, 2020.
-
Abstract
- India is the second most populous country in the world with a population of nearly 1.3 billion, comprising 20% of the global population. There are an estimated 37.5 million cases of asthma in India, and recent studies have reported a rise in prevalence of allergic rhinitis and asthma. Overall, 40–50% of paediatric asthma cases in India are uncontrolled or severe. Treatment of allergic rhinitis and asthma is sub-optimal in a significant proportion of cases due to multiple factors relating to unaffordability to buy medications, low national gross domestic product, religious beliefs, myths and stigma regarding chronic ailment, illiteracy, lack of allergy specialists, and lack of access to allergen-specific immunotherapy for allergic rhinitis and biologics for severe asthma. High quality allergen extracts for skin tests and adrenaline auto-injectors are currently not available in India. Higher postgraduate specialist training programmes in Allergy and Immunology are also not available. Another major challenge for the vast majority of the Indian population is an unacceptably high level of exposure to particulate matter (PM)2.5 generated from traffic pollution and use of fossil fuel and biomass fuel and burning of incense sticks and mosquito coils. This review provides an overview of the burden of allergic disorders in India. It appraises current evidence and justifies an urgent need for a strategic multipronged approach to enhance quality of care for allergic disorders. This may include creating an infrastructure for education and training of healthcare professionals and patients and involving regulatory authorities for making essential treatments accessible at subsidised prices. It calls for research into better phenotypic characterisation of allergic disorders, as evidence generated from high income western countries are not directly applicable to India, due to important confounders such as ethnicity, air pollution, high rates of parasitic infestation, and other infections.
- Subjects :
- GDP, Gross Domestic Product
Allergy
NMBA, Neuromuscular blocking agents
Gross domestic product
0302 clinical medicine
Continuing medical education
DALY, Disability Associated Life Years
Immunology and Allergy
INR, Indian Rupees
A&I, Allergy and Immunology
030223 otorhinolaryngology
USA, United States of America
Functional illiteracy
SLIT, Sublingual Immunotherapy
education.field_of_study
BTS, British Thoracic Society
Atopic dermatitis
Allergic bronchopulmonary aspergillosis
CME, Continuing Medical Education
Pulmonary and Respiratory Medicine
lcsh:Immunologic diseases. Allergy
USD, United States Dollars
GINA, Global Initiative for Asthma
ISAAC, International Study of Asthma and Allergies in Childhood
AD, Atopic Dermatitis
SAFS, Severe Asthma and Fungal Sensitisation
Immunology
Population
IHDS, Indian Human Development Survey
Article
DBPCFC, Double Blind Placebo Controlled Food Challenge
WHO, World Health Organization
03 medical and health sciences
Environmental health
SCIT, Subcutaneous Injection Immunotherapy
medicine
ABPA, Allergic Bronchopulmonary Aspergillosis
education
AB-NHPS, Ayushman Bharath National Health Protection Scheme
Asthma
ELISA, Enzyme Linked Immunosorbent Assay
PAFs, Population Attributable Factors
business.industry
COPD, Chronic Obstructive Pulmonary Disease
ETS, Environmental Tobacco Smoke
medicine.disease
ICAAI, Indian College of Allergy Asthma and Applied Immunology
030228 respiratory system
SPT, Skin Prick Test
business
lcsh:RC581-607
Subjects
Details
- Language :
- English
- ISSN :
- 19394551
- Volume :
- 13
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- World Allergy Organization Journal
- Accession number :
- edsair.doi.dedup.....3a9824a3583297bee1fbedc3266361f9